Brachytherapy for Prostate Cancer: Targeted, Minimally Invasive Treatment at Healthcare International
Introduction
At Healthcare International, we specialize in brachytherapy,
an internal radiation therapy that delivers powerful and precise doses directly
into the prostate. As a highly effective, minimally invasive option, our
brachytherapy services offer cancer control comparable to surgery—while
preserving urinary and sexual function.
1. What Is Brachytherapy?
Brachytherapy includes two main types:
- Low-Dose-Rate
(LDR) seed implantation – permanent placement of radioactive seeds
(e.g., iodine‑125, palladium‑103) directly into the prostate.
- High-Dose-Rate
(HDR) temporary implants, often as a boost adjunct to external beam
radiation.
This technique delivers radiation very locally, minimizing
exposure to nearby organs like the bladder and rectum. The outpatient procedure
typically requires no incision and patients often resume normal activities
within a day or two.
2. Cancer Control: Real-World Outcomes
Evidence supports brachytherapy as a highly effective
treatment:
- A
study showed 7-year PSA relapse-free survival (PRFS) of 95%
for LDR brachytherapy vs. 89% for IMRT alone (P=0.004).
- A
comparative cohort of 557 patients showed 5‑year biochemical
recurrence-free survival rates: low risk 95.2%, intermediate 91.0%,
high risk 76.1%—on par with radical prostatectomy patients (~90–96%).
- Meta-analyses
confirm brachytherapy outcomes are non-inferior to both radical
prostatectomy and EBRT, with similarly high long-term survival rates.
3. Quality of Life: Preservation is Paramount
✅ Urinary and Sexual Function
- Compared
to surgery, brachytherapy generally results in less urinary
incontinence and improved sexual function outcomes. Erectile
dysfunction occurs in approximately 15–30%, versus higher rates in
surgery or EBRT.
- In
comparative analyses, brachytherapy patients had better continence
than radical prostatectomy and lower erectile dysfunction rates
than external beam therapy at 3 years follow-up.
⚠️ Transient Irritative Symptoms
- Short-term
urinary irritation (dysuria, frequency) and occasional bowel discomfort
may occur in the months following implantation. These symptoms typically
resolve within weeks to months.
- Grade 2 late urinary toxicity
reported in ~15.6%, rectal bleeding ~5.1%, vs. lower rates in EBRT—though Grade 3
toxicity remains rare (<2%).
4. Advantages of Brachytherapy at Healthcare International
🎯 Precision & Efficiency
- Experience
with real-time imaging, computer‑based planning, and polymer‑coated
seed technologies ensures optimal dose distribution while sparing normal
tissue.
- Brachytherapy
can be delivered as a single outpatient session, with minimal
recovery time and no major surgery.
👥 Patient-Centered Approach
- Ideal
for low to intermediate risk patients, particularly those seeking
effective treatment with quick recovery.
- Also
suitable as a boost with EBRT for higher risk cases, tailored by
clinical team based on PSA, Gleason, and MRI findings.
🌍 Global Standards & Expertise
- Aligned
with guidelines from the American Brachytherapy Society and international
consensus, our protocols are designed to ensure safety, precision, and
consistency across patient populations.
📋 Summary Table
|
Benefit |
Brachytherapy at Healthcare International |
|
Delivery method |
LDR permanent seeds or HDR temporary implants |
|
Cancer control (5–7 year) |
PRFS ~95%, DMFS 100%, comparable to EBRT and surgery |
|
Urinary incontinence |
Lower than surgery; rare long-term incontinence |
|
Erectile function preservation |
~70–85% potency preservation; better than surgery/EBRT |
|
Side effects |
Mild urinary or bowel irritation; low long-term toxicity |
|
Recovery |
Outpatient, quick return to daily life |
Patient Insights: Real Experiences
Reddit and patient forums echo favorable outcomes:
“10–15% impotence rate, treatable with meds… very low
recurrence after 7 years… walk out same day… return to normal activities
immediately” .
“Dysuria and frequency were the worst parts, but they
dissipated. Side effects resolved over time” .
Conclusion
Brachytherapy is a proven, minimally invasive cancer
treatment that offers targeted, lasting control with fewer side effects and
fast recovery. At Healthcare International, we deliver this
international standard therapy with precision, care, and personalized
protocols.
If you or a loved one is evaluating prostate cancer
therapies—and you value quality-of-life, convenience, and expert care—HealthcareInternational is ready to guide your path. Contact us today to see if
brachytherapy is the right option for your treatment journey.
Comments
Post a Comment